News | Analytics Software | October 30, 2015

Societies Release Statement on the Future of Clinical Registries

Registries can support development, implementation and evaluation of performance measures

October 30, 2015 — The American College of Cardiology, the American Heart Association and The Society of Thoracic Surgeons released a new statement in early October on the future of clinical registries titled ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise.

Clinical registries are observational databases focused on clinical conditions, procedures, therapies or populations. The goal of registries is to capture data that reflect real-world clinical practice in patient populations.

“Registries are fundamental to healthcare quality and improvement,” said Deepak L. Bhatt, M.D., M.P.H., FACC, FAHA, executive director of intervention cardiovascular programs at Brigham and Women’s Hospital Heart and Vascular Center, professor of medicine at Harvard Medical School, and chair of the writing committee. “Registries can support the development, implementation and evaluation of performance measures as tools for improving patient care and communicating meaningful information to patients regarding quality.”

The statement examines the current state of clinical registries while acknowledging their future growth potential.  The authors write that while there has been an “explosion” in the number of clinical registries over the past decade, there are still broad clinical areas and specific procedures that would benefit from the creation of a dedicated registry.

“The future will likely involve some degree of integration of electronic health records and administrative data sources with registry data,” Bhatt said.

The document was published online in the Journal of the American College of Cardiology, Circulation: Cardiovascular Quality and Outcomes and The Annals of Thoracic Surgery.

For more information: www.acc.org, www.heart.org, www.sts.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init